Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2M Sell
134,448
-1,951
-1% -$193K 0.33% 62
2026
Q1
$12.8M Sell
136,399
-4,942
-3% -$493K 0.36% 61
2025
Q4
$14M Sell
141,341
-21,791
-13% -$2.11M 0.33% 58
2025
Q3
$13.8M Sell
163,132
-16,883
-9% -$1.33M 0.34% 60
2025
Q2
$12.3M Sell
180,015
-4,218
-2% -$267K 0.33% 67
2025
Q1
$11.2M Buy
184,233
+403
+0.2% +$28.1K 0.34% 68
2024
Q4
$12.7M Sell
183,830
-93
-0.1% -$6.63K 0.37% 61
2024
Q3
$12.2M Sell
183,923
-8,372
-4% -$534K 0.33% 68
2024
Q2
$11.7M Buy
192,295
+7,202
+4% +$408K 0.35% 66
2024
Q1
$10.5M Buy
185,093
+88,338
+91% +$5.3M 0.32% 75
2023
Q4
$6.08M Sell
96,755
-92,723
-49% -$5.24M 0.2% 90
2023
Q3
$10.9M Buy
189,478
+2,562
+1% +$161K 0.42% 58
2023
Q2
$11.6M Buy
186,916
+1,725
+0.9% +$115K 0.41% 58
2023
Q1
$13.4M Sell
185,191
-10,224
-5% -$800K 0.55% 44
2022
Q4
$15.7M Sell
195,415
-7,348
-4% -$562K 0.66% 26
2022
Q3
$13.5M Sell
202,763
-2,462
-1% -$182K 0.71% 27
2022
Q2
$15.6M Sell
205,225
-1,992
-1% -$151K 0.79% 22
2022
Q1
$16.5M Buy
207,217
+14,972
+8% +$1.09M 0.86% 32
2021
Q4
$14.1M Buy
192,245
+1,493
+0.8% +$101K 0.65% 44
2021
Q3
$13.1M Buy
+190,752
New +$14.5M 0.57% 47

Other funds holding INCY

Grimes & Company's INCY Position: Q2 2026 in Review

Grimes & Company reduced its Incyte (INCY) stake by 1.4% in Q2 2026, selling an estimated $193K and leaving 134,448 shares worth $15.2M. The position accounts for 0.33% of the portfolio, ranked #62.

Grimes & Company first reported a position in INCY in Q3 2021 and has held it in 20 quarters since. The position peaked at $16.5M in Q1 2022. 279 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Grimes & Company held 134,448 shares of Incyte worth $15.2M as of Q2 2026.
  • Grimes & Company sold 1,951 Incyte shares in Q2 2026, an estimated $193K.
  • Incyte made up 0.33% of Grimes & Company's portfolio in Q2 2026, its #62 holding.
  • Grimes & Company first reported a position in Incyte in Q3 2021 and has held it in 20 quarters since.
  • Grimes & Company's Incyte position peaked at $16.5M in Q1 2022.
  • 279 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.